Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 2,700 | 4,975 | 5,987 | 3,253 | 2,409 |
| Operating Income | -2,700 | -4,975 | -5,987 | -3,253 | -2,409 |
| Interest Expense | 4 | 6 | 3 | 2 | 4 |
| Other Income | 116 | 44 | 34 | 37 | 38 |
| Pre-tax Income | -2,588 | -4,937 | -5,956 | -3,219 | -2,375 |
| Net Income Continuous | -2,588 | -4,937 | -5,956 | -3,219 | -2,375 |
| Net Income | $-2,588 | $-4,937 | $-5,956 | $-3,219 | $-2,375 |
| EPS Basic Total Ops | -0.38 | -7.30 | -4.64 | -5.76 | -6.42 |
| EPS Basic Continuous Ops | -0.38 | -7.30 | -4.66 | -5.76 | -6.42 |
| EPS Diluted Total Ops | -0.38 | -7.30 | -4.64 | -5.76 | -6.42 |
| EPS Diluted Continuous Ops | -0.38 | -7.30 | -4.66 | -5.76 | -6.42 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -7.30 | -10.15 | -5.76 | -6.42 |
| EBITDA(a) | $-2,689 | $-4,973 | $-5,986 | $-3,253 | $-2,408 |